Distinguishing patients with stage i lung cancer versus control individuals using serum mass profiling

Autor: Hanas, JS, Peyton, MD, Lerner, MR, Lightfoot, SA, Deb, SJ, Hanas, RJ, Vu, NT, Kupiec, TC, Stowell, DE, Brackett, DJ, Dubinett, SM, Hocker, JR

Publikováno v: Hanas, JS; Peyton, MD; Lerner, MR; Lightfoot, SA; Deb, SJ; Hanas, RJ; et al.(2014). Distinguishing patients with stage i lung cancer versus control individuals using serum mass profiling. Cancer Investigation, 32(4), 136-143. doi: 10.3109/07357907.2014.883528. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3gp251nb

Serum mass profiling can discern physiological changes associated with specific disease states and their progression. Sera (86 total) from control individuals and patients with stage I nonsmall cell lung cancer or benign small pulmonary nodules were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::f7cb4c68aeea99ab4a764431c93f1b9d
http://www.escholarship.org/uc/item/3gp251nb

Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.

Autor: Hocker JR; Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Postier RG; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Li M; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Lerner MR; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Veterans Affairs Medical Center, Oklahoma City, OK, United States., Lightfoot SA; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Peyton MD; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Deb SJ; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Baker CM; Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Williams TL; Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Hanas RJ; Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Stowell DE; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Lander TJ; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Brackett DJ; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Hanas JS; Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Veterans Affairs Medical Center, Oklahoma City, OK, United States. Electronic address: jay-hanas@ouhsc.edu.

Publikováno v: Cancer letters [Cancer Lett] 2015 Apr 10; Vol. 359 (2), pp. 314-24. Date of Electronic Publication: 2015 Jan 28.